Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China · Delayed Price · Currency is CNY 9.69
-0.24 (-2.42%)
Nov 13, 2026, 3:00 PM CST
SHA:603998 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,877 | 1,746 | 1,777 | 1,629 | 1,792 | 1,567 |
Revenue Growth | 11.56% | -1.75% | 9.15% | -9.12% | 14.36% | 22.54% |
Gross Profit Gross Profit Growth | 1,397 | 1,250 | 1,260 | 1,106 | 1,203 | 1,001 |
Operating Income Operating Income Growth | 375.35 | 304.61 | 247.14 | 163.31 | 153.98 | 123.37 |
Net Income Net Income Growth | 326.78 | 306.39 | 255.22 | 186.82 | 285.85 | 70.04 |
Earnings Per Share EPS Growth | 0.75 | 0.70 | 0.58 | 0.42 | 0.66 | 0.16 |
EPS Growth | 11.90% | 20.69% | 38.09% | -36.36% | 312.50% | 6.67% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pharmaceutical Manufacturing Business Pharmaceutical Manufacturing Business Growth | 1,648 |
Intersegment Offset Intersegment Offset Growth | -47.83 |
Other Other Growth | 88.41 |
Total Total Growth | 1,689 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 248.3 | 276.25 | 308.46 | 229.3 | 440.03 | 274.3 |
Total Debt Total Debt Growth | 216.52 | 432.03 | 700.15 | 681.93 | 594.3 | 552.05 |
Net Cash (Debt) Net Cash Growth | 31.77 | -155.78 | -391.69 | -452.62 | -154.26 | -277.75 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.07 | -0.36 | -0.89 | -1.02 | -0.36 | -0.63 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 586.94 | 384.63 | 194.95 | 87.54 | 301.63 | 185.63 |
Capital Expenditures CapEx Growth | -103.79 | -102.52 | -94.79 | -218.78 | -171.25 | -184.71 |
Free Cash Flow Free Cash Flow Growth | 483.15 | 282.12 | 100.16 | -131.24 | 130.38 | 0.92 |
Free Cash Flow Growth | 115.70% | 181.67% | - | - | 14138.22% | -98.67% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 74.39% | 71.56% | 70.91% | 67.93% | 67.12% | 63.86% |
Operating Margin | 19.99% | 17.44% | 13.90% | 10.03% | 8.59% | 7.87% |
Pretax Margin | 21.04% | 20.23% | 16.09% | 12.49% | 18.22% | 5.79% |
Profit Margin | 17.41% | 17.54% | 14.36% | 11.47% | 15.95% | 4.47% |
FCF Margin | 25.74% | 16.15% | 5.63% | -8.06% | 7.28% | 0.06% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.300 | 0.250 | 0.290 | 0.350 | 0.150 |
Dividend Per Share Growth | 0% | 20.00% | -13.79% | -17.14% | 133.33% | 25.00% |
Dividend Yield | 5.16% | 2.67% | 2.40% | 2.65% | 4.37% | 2.21% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.93 | 16.11 | 17.93 | 25.80 | 12.32 | 41.69 |
Forward PE | 11.67 | 15.04 | 16.49 | 24.91 | 63.00 | 63.00 |
P/FCF Ratio | 8.81 | 17.49 | 45.69 | - | 27.01 | 3188.95 |
PS Ratio | 2.27 | 2.83 | 2.57 | 2.96 | 1.97 | 1.86 |